COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 499: Articles 4981-4990  | Next

Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine, in non-human primates
Prenafeta, A., Bech-Sabat, G., Moros, S., Barreiro, A., Fernandez, A., Canete, M., Roca, M., Gonzalez, L., Garriga, C., Confais, J., Toussenot, M., Contamin, H., Pradenas, E., Marfil, S., Blanco, J., Cebollada Rica, P., Sistere-Oro, M., Meyerhans, A., Pizzorno, A., Rosa-Calatrava, M., Prat Cabanas, T., March, R., Ferrer, L.
10.1101/2022.12.13.520255 — Posted: 2022-12-13
Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Cote dIvoire
Simons, E., Nikolay, B., Ouedraogo, P., Pasquier, E., Tiemeni, C., Adjaho, I., Badjo, C., Chamman, K., Diomande, M., Dosso, M., Doumbia, M., Izia, Y. A., Kakompe, H., Katsomya, A. M., Kij, V., Akissi, V. K., Mambula, C., Mbala-Kingebeni, P., Muzinga, J., Ngoy, B., Penali, L., Pini, A., Porten, K., Salou, H., Sevede, D., Luquero, F., Gignoux, E.
10.1101/2022.12.12.22283387 — Posted: 2022-12-13
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection
Perez-Saez, J., Zaballa, M.-E., Lamour, J., Yerly, S., Dubos, R., Courvoisier, D., Villers, J., Balavoine, J.-F., Pittet, D., Kherad, O., Vuilleumier, N., Kaiser, L., Guessous, I., Stringhini, S., Azman, A. S.
10.1101/2022.12.13.22283400 — Posted: 2022-12-13
Long COVID: G Protein-Coupled Receptors (GPCRs) responsible for persistent post-COVID symptoms
Das, S., Kumar, S.
10.1101/2022.12.12.520110 — Posted: 2022-12-13
A Photonic Resonator Interferometric Scattering Microscope for Label-free Detection of Nanometer-Scale Objects with Digital Precision in Point-of-Use Environments
Liu, L., Tibbs, J., Li, N., Bacon, A., Shephard, S., Lee, H., Chauhan, N., Demirci, U., Wang, X., Cunningham, B. T.
10.1101/2022.12.13.520266 — Posted: 2022-12-13
Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS-CoV-2 Subunit Vaccine
Ou, B. S., Saouaf, O. M., Yan, J., Bruun, T. U. J., Baillet, J., King, N. P., Appel, E.
10.1101/2022.12.12.520166 — Posted: 2022-12-13
BCG vaccination of healthcare workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomised placebo-controlled trial
Claus, J., ten Doesschate, T., Gumbs, C., van Werkhoven, C. H., van der Vaart, T. W., Janssen, A. B., Smits, G., van Binnendijk, R., van der Klis, F., van Baarle, D., Paganelli, F. L., Leavis, H., Verhagen, L. M., Joosten, S. A., Bonten, M. J. M., Netea, M. G., van de Wijgert, J. H.
10.1101/2022.12.12.22283282 — Posted: 2022-12-13
The COVID-19 pandemic and its prolonged impacts on food prices, food consumption and diet quality in sub-Saharan Africa
Madzorera, I., Ismail, A., Apraku, E. A., Tinkasimile, A., Dasmane, D., Zabre, P., Ourohire, M., Assefa, N., Chukwu, A., Workneh, F., Mapendo, F., Lankoande, B., Hemler, E., Wang, D., Abubakari, S. W., Asante, K. P., Baernighausen, T., Killewo, J., Oduola, A., Sie, A., Soura, A., Vuai, S., Smith, E., Berhane, Y., Fawzi, W. W.
10.1101/2022.12.12.22283393 — Posted: 2022-12-13
Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
Liu, X., Park, H.-S., Matsuoka, Y., Santos, C., Yang, L., Luongo, C., Moore, I., Johnson, R., Garza, N., Zhang, P., Lusso, P., Best, S., Buchholz, U., Le Nouën, C.
10.1101/2022.12.12.520032 — Posted: 2022-12-13
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants
Wu, J., Chen, Z., Gao, Y., Wang, Z., Wang, J., Chiang, B.-Y., Zhou, Y., Han, Y., Zhan, W., Xie, M., Jiang, W., Zhang, X., Hao, A., Xia, A., He, J., Xue, S., Mayer, C. T., Wu, F., Wang, B., Zhang, L., Sun, L., Wang, Q.
10.1101/2022.12.12.520172 — Posted: 2022-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).